首页> 外国专利> 58 Monoclonal Antibody 5E8 specific to West Nile Virus its Hybridoma and Enzyme-linked Immunosorbent Assay

58 Monoclonal Antibody 5E8 specific to West Nile Virus its Hybridoma and Enzyme-linked Immunosorbent Assay

机译:西尼罗河病毒58单克隆抗体5E8及其杂交瘤和酶联免疫吸附测定

摘要

The present invention relates to a diagnostic method using the fused cell lines and the monoclonal antibodies that secrete monoclonal antibodies binding to the region of the outer covering E367 alanine E protein of West Nile virus. ; The object of the invention is coupled to E367 alanine portion of the shell E protein of West Nile virus, providing a fused cell line secreting a neutralizing monoclonal antibody 5E8 which inhibits the virus in infection sensitive cells, and is secreted from here that the 5E8 monoclonal antibody utilized to provide a new diagnostic method for rapidly detecting the West Nile virus neutralizing antibodies. ; More specifically, the fused cell lines of the present invention is prepared by the cell fusion between the West Nile B immune cells of said immune to viral antigens valves (Balb / c) mice with SP2 / 0 myeloma-derived cell, West Nile virus E sheath characterized in that the secreted monoclonal antibodies that bind to a neutralization site of protein E367 alanine. Also it provides a diagnostic method which can be rapidly detected in the binding competitively enzyme immunoassay neutralizing antibodies to West Nile virus infection time by using the monoclonal antibody 5E8. ; Monoclonal antibody produced by the fused cell line of the present invention can be used to hold it and the ability to neutralize the West Nile Virus, as well as a diagnostic antibody therapeutic antibody development. Diagnostic method of the novel present invention can be used for serum diagnosis, regardless of the animal species, West Nile can quickly measure the infection defense antibody levels in the vaccinated individual in order to prevent virus. ; West Nile virus, monoclonal antibodies, neutralizing antibodies, competitively enzyme-linked immunoassay
机译:本发明涉及使用融合细胞系和分泌与西尼罗河病毒的外壳E367丙氨酸E蛋白的区域结合的单克隆抗体的单克隆抗体的诊断方法。 ;本发明的目的与西尼罗河病毒的壳E蛋白的E367丙氨酸部分偶联,提供融合细胞系,其分泌中和性单克隆抗体5E8,该中和性单克隆抗体抑制感染敏感细胞中的病毒,并据此分泌5E8单克隆抗体。抗体用于提供一种新的诊断方法,用于快速检测西尼罗河病毒中和抗体。 ;更具体地说,本发明的融合细胞系是通过所述的对病毒抗原瓣膜(Balb / c)小鼠免疫的West Nile B免疫细胞与SP2 / 0骨髓瘤来源的细胞,West Nile病毒E之间的细胞融合而制备的。鞘的特征在于,分泌的单克隆抗体与蛋白E367丙氨酸的中和位点结合。还提供了一种诊断方法,该方法可以通过使用单克隆抗体5E8在针对西尼罗河病毒感染时间的竞争性酶联免疫中和抗体的结合中快速检测到。 ;由本发明的融合细胞系产生的单克隆抗体可用于保持其和中和西尼罗河病毒的能力,以及诊断性抗体治疗性抗体的开发。本发明的诊断方法可用于血清诊断,无论动物是什么种类,西尼罗河都能快速测量接种个体中的感染防御抗体水平以预防病毒。 ;西尼罗河病毒,单克隆抗体,中和抗体,竞争性酶联免疫法

著录项

  • 公开/公告号KR100758816B1

    专利类型

  • 公开/公告日2007-09-19

    原文格式PDF

  • 申请/专利权人 대한민국;

    申请/专利号KR20050085911

  • 发明设计人 최강석;고영준;나진주;조남인;

    申请日2005-09-14

  • 分类号C07K16;C12N5/12;

  • 国家 KR

  • 入库时间 2022-08-21 20:31:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号